Concepedia

Publication | Closed Access

Incidence and Causes for Early Ticagrelor Discontinuation: A “Real-World” Dutch Registry Experience

DOI

39

Citations

8

References

2017

Year

Thomas O. Bergmeijer, Paul W.A. Janssen, Mathijs van Oevelen, Dymphie van Rooijen, Thea C. Godschalk, Johannes C. Kelder, Vera H.M. Deneer, Victor L. Serebruany, Jurriën M. ten Berg
Cardiology

Abstract

Almost one quarter of ticagrelor patients were discontinued prematurely or switched to another antiplatelet agent within 1 year, mostly due to dyspnea or bleeding.

References

YearCitations

Page 1